使用445纳米蓝激光治疗早期声门癌:初步1年结果
单机构回顾性图表回顾,比较445纳米蓝激光(BL)与532纳米磷酸钛氧钾(KTP)激光显微喉镜下切除早期声门癌的肿瘤学与嗓音结局。BL组49例、KTP组88例,平均随访分别为635天和1236天;两组疾病特异性生存率、器官保留率、局部控制率无显著差异,术后CAPE-V与VHI-10评分均显著改善。作者认为BL在至少1年随访时与KTP同样安全有效且嗓音结局良好,并指出需随时间开展进一步研究评估BL长期结局。
要点
- BL组49例与KTP组88例早期声门癌患者,平均随访分别为635天与1236天。
- 疾病特异性生存率BL 95.9% vs KTP 100%(p=0.13),无显著差异。
- 术后两组CAPE-V与VHI-10评分均显著改善,嗓音结局良好。
核心结论
- 作者认为,在至少1年随访时,用BL对早期声门癌行光血管溶解性切除似乎与KTP激光同样安全有效,且嗓音结局良好。
- 作者指出,随着时间推移需开展进一步研究以评估BL患者的长期结局。
研究设计与样本
- 单机构、回顾性图表回顾。
- 纳入2018年至今接受显微喉镜下KTP或BL激光切除早期声门癌且随访至少1年的所有患者,包括原发与复发病例(含放疗和手术失败者)。
- BL组49例,KTP组88例,比较两组人口学数据、嗓音结局与肿瘤学结局。
主要发现
- BL组平均随访635天,KTP组平均随访1236天。
- 疾病特异性生存率BL组95.9% vs KTP组100%(p=0.13),两组无显著差异。
- 器官保留率BL组98.0% vs KTP组95.6%(p=0.39),两组无显著差异。
- 局部控制率BL组93.9% vs KTP组92.1%(p=0.81),两组无显著差异。
- 术后BL组与KTP组CAPE-V评分均显著改善(分别为p=0.04、p=0.006),VHI-10评分均显著改善(分别为p=0.003、p<0.00001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze oncological efficacy and voice outcomes of the 445-nm blue laser (BL) in the treatment of early glottic carcinoma and compare results with the 532-nm potassium-titanyl-phosphate (KTP) laser. STUDY DESIGN: Single institution, retrospective chart review. METHODS: All patients who underwent microlaryngoscopic KTP or BL laser excision of early glottic carcinoma from 2018 to the present day with at least 1-year follow-up were included. Primary and recurrent disease, including radiation and surgical failures, were included. Demographic data, voice outcomes and oncologic outcomes were compared between the two laser groups. RESULTS: Forty-nine patients met the inclusion criteria for the BL group and 88 for the KTP group, with average follow-up of 635 and 1236 days, respectively. Oncologic outcomes were not significantly different, with disease-specific survival rates of 95.9% for BL and 100% for KTP (p = 0.13), organ preservation rates of 98.0% for BL and 95.6% for KTP (p = 0.39), and local control rates of 93.9% for BL and 92.1% for KTP (p = 0.81). Both BL and KTP groups showed significant improvement in CAPE-V (p = 0.04, 0.006 respectively) and VHI-10 scores (p = 0.003, <0.00001) following surgery. CONCLUSIONS: Photoangiolytic removal of early glottic carcinoma with BL appears to be equally safe and effective as with KTP laser at minimum one-year follow-up, and with excellent voice outcomes. Additional study will be warranted over time to assess long-term outcomes in BL patients. LEVEL OF EVIDENCE: 3 Laryngoscope, 134:4656-4660, 2024.
引用
- Rosow DE, Keidar E, Pasick LJ, et al. Use of the 445-nm Blue Laser for Management of Early Glottic Carcinoma: Preliminary 1-Year Results. Laryngoscope. 2024. PMID: 38860434. doi:10.1002/lary.31569
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。